Purpose This study explores what dimensions of a healthrelated quality of life (HRQOL) questionnaire predict global ratings of overall quality of life (QOL) in lung cancer patients in assessments by patients and significant others, respectively. Material and methods The analyses were based on dyadic assessments from lung cancer patients and their significant others. A subset of scales and items from the Swedish version of the European Organization for Research and Treatment of Cancer (EORTC) QLQ C30 and the lungcancer-specific module, LC-13, was selected. Using multiple regression procedures, the relative importance of different symptoms and of functional impairments in predicting overall QOL was examined. Results The multiple regressions revealed that emotional functioning and fatigue were the only significant predictors of overall QOL for both the patients and the significant others' assessments. In addition, physical functioning was found to be another predictor in the significant others' assessments. Conclusion The results emphasize that it is essential to consider both emotional functioning and fatigue as important areas for overall QOL in lung cancer patients.
Introduction
Lung cancer is the most common incident form of cancer in Europe and the largest cause of cancer death [7] . Patients with lung cancer are often diagnosed with advanced disease, and more than 90% are symptomatic at presentation [4] . Because these patients experience multiple symptoms, experience a great degree of symptom distress [10] , and have a short life expectancy [16] , palliative treatment is often the first and only choice for therapy [8] and palliative care is applicable early in the illness trajectory [25] . In palliative care, achievement of the best quality of life (QOL) for the patient and the family is the main goal [25] , and QOL has been suggested as a primary endpoint in the management of lung cancer [8] . Therefore, the understanding of the concept QOL is of interest to these patients and their families. In today's health care organization, significant others play a major role in the care of the patients and have been found to be a reliable alternative source when collecting information from cancer patients who can no longer share their experiences themselves [22] .
The concept 'quality of life' (QOL) is often used in research but no precise definition has been agreed on. Two main types of QOL can be used to understand the concept on an individual level in health care, namely, one overall broad concept and another more specific one, which is referred to as health-related quality of life (HRQOL) [21] . Even if there is no consensus, some definitions of overall QOL that have become widely accepted are available in the literature [19] . The World Health Organization project to develop a QOL assessment instrument (WHOQOL) has, for example, defined overall QOL as the "individual's perceptions of their position in life in the context of the culture and value system in which they live and in relation to their goals, standards and concerns" [26] . Definitions of HRQOL and what aspects should be included for measurement are still unclear, but there is agreement that HRQOL is a multidimensional construct, and relevant aspects may vary from study to study [12] . The European Organization on Research and Treatment of Cancer (EORTC) Study Group on QOL [1] have identified general aspects of HRQOL that they consider important for cancer patients. These aspects incorporate physical-, role-, cognitive-, emotional-, and social functioning, together with several symptoms and impact on finances.
Cooley [9] has proposed that HRQOL is an antecedent to overall QOL and that it is important to differentiate between HRQOL and overall QOL in lung cancer patients. Although there are several publications on QOL in lung cancer patients, there is no or little empirical evidence concerning the relation between different dimensions of HRQOL measures and global ratings of overall QOL. The aim of this study was to explore what dimensions of a HRQOL questionnaire predict global ratings of overall QOL in lung cancer patients in assessments by patients and significant others, respectively.
Materials and methods

Study design and sample
The patients and significant others were recruited from the two lung medicine departments in the Stockholm area via an ongoing large-scale longitudinal project on symptom distress in lung cancer [23] . Data from a study on factors influencing agreement in symptom ratings by patients and their significant others were used for the analysis [24] , thus, providing the opportunity to explore both the patient and the significant other assessments of the patients' QOL. Patients and significant others made a dyadic assessment of the patients' HRQOL and overall QOL within 1 week of each other at one of six original data collection time points in the longitudinal project. This allowed for a variation in disease and treatment phases and, as a result, in symptom occurrence and intensity.
A total of 72 consecutive patients were approached under the settled period concerning recruitment of a significant other. Two of these did not want to disturb their significant others, and two chose not to continue participation themselves. Eight of the remaining 68 patients died before the planned assessment, which left 60 patients who agreed to participate. Among the eligible significant others, five declined participation, one could not be reached, and two significant other assessments could not be coordinated with the patient assessment. The analyses were, therefore, based on dyadic assessments from 52 significant others (23 men and 29 women) aged 23-86 years and 52 patients (26 men and 26 women) aged 46-84 years. Forty-four of the significant others lived with the patient as a spouse; five were adult children and one was a sister. Twenty-eight worked full-time, 2 part-time, and 22 were retired. For patient characteristics, see Table 1 . Ethical approval for the study was obtained from the Research Ethics Committee at Karolinska Institutet (KI Dnr: 97-258, KI Dnr: 98-318).
Instruments
Both the significant others and the patients completed the EORTC QLQ C30 [1] and the lung-cancer-specific module, LC13 [5] , with the significant others responding to an adapted instrument focusing on 'how they perceived the patient's situation.' The EORTC QLQ C30 is a cancerspecific QOL instrument developed for measuring HRQOL in clinical trials. The instrument consists of 30 items, with 6 items used as single items and the rest constituting nine multi-item subscales. One of the single items provides a global rating of overall QOL and one of overall health. The rest of the items and scales measure different dimensions of HRQOL. The LC 13 is a lung-cancer-specific module with 13 symptom items. For the items in both instruments, there are four response alternatives (not at all, a little, quite a bit, and very much), except for the global items on overall health and QOL, which have a 7-point response scale ranging from very poor to excellent. The response scores are transformed into a 0-100 score index with high scores on both instruments indicating either good functioning and overall QOL or high symptomatology. Scores are calculated by scale or item rather than for the instrument as a whole. The instruments have been found to have high validity and reliability [1, 5] . A validated Swedish translation was used in this study [1, 5] .
Study variables
A subset of scales and items in the patient and significant other assessments was selected for analysis from the EORTC QLQ C30 and the LC13. As outcome variables, the single item providing a global rating of overall QOL from EORTC QLQ C30 was chosen. To measure the HRQOL predictors for the patients' overall QOL, the scales for physical, emotional, cognitive, social, and role functioning were used. Cancer symptoms (fatigue, nausea, pain, insomnia, appetite loss, constipation, and diarrhoea) and financial difficulties in the EORTC QLQ C30, and dyspnea and cough using the lung-cancer-specific LC13 were also selected as independent variables. Internal consistency in the present study was measured by Cronbach's alpha, with patient assessments ranging from 0.55-0.87 (mean interitem correlation, 0.39-0.75), with seven of nine scales >0.70 and one scale (cognitive functioning) <0.60. For significant others, the Cronbach's alpha ranged between 0.44 and 0.90 (mean inter-item correlation, 0.29-0.82) with eight of nine scales >0.70 and cognitive functioning <0.50.
Data analysis
First, zero-order Pearson correlations were computed in the patient and the significant other samples, respectively, between all symptom and functional variables and the outcome variables (i.e., the patient's overall QOL assessed by the patient and the significant others). In a second step, a linear multiple regression procedure was used to evaluate the relative importance of different symptoms and functional impairments in predicting overall QOL. Because it has been proposed that symptom status has no direct effect on overall QOL but is an important determinant for functioning [27] , two separate models were computed. In the first model, the 10 symptom variables were entered simultaneously to the regression equation, and in the other, the five functioning variables were entered simultaneously. Finally, two additional linear multiple regression models were computed. First, variables found to be statistically significant (in the previous regression analyses) for the patients and the significant others, respectively, were entered concurrently as independent variables in predicting overall QOL. In addition, variables found to be significant in either of the patient and significant other assessments were entered simultaneously as predictors for overall QOL. The regression analyses were computed in both the patient and the significant other samples. Levels for significance were set to p≤0.05.
Results
All of the function scales in the patients' and significant others' assessments were significantly correlated with the overall QOL except for physical functioning in the patients' assessments (see Table 2 ). As regards the symptom variables, fatigue, nausea, pain, and appetite loss were significantly correlated with overall QOL. The results from the linear multiple regression analyses that were used to evaluate the relative importance of different symptoms and functional scales in predicting overall QOL are summarized in Table 3 . Among the functional scales, only emotional functioning had a significant partial correlation with overall QOL in the patients' assessments. In the significant others' assessments, both emotional functioning and physical functioning predicted overall QOL. Moreover, among the symptom scales, fatigue was the only significant predictor of overall QOL, and the result was the same among both patients and significant others. The functional scales together explained 27% of the variance in overall QOL in the patients group and 46% in the significant others group. The symptoms together explained 22% of the variance in both the patients' and the significant others' group.
In the linear multiple regression analysis, when the variables found to be significant as predictors of overall QOL for both the patients and the significant others in the previous regression analyses were entered, both emotional functioning and fatigue were found to independently predict overall QOL in the patients' and significant others' assessments ( Table 4 ). The variance explained in this model were 28% in the patients group and 42% in the significant others' group. In the regression analysis where all variables found to be significant in either of the patients' and significant others' assessments were entered as predictors for overall QOL, only emotional functioning was found to independently predict overall QOL in the patients' assessments, while physical functioning and the symptom 'fatigue' did not. In the significant others' assessments, both physical and emotional functioning were found to independently predict overall QOL, while fatigue did not (Table 5) . This model explained 27% of the variance in overall QOL in the patients group and 47% in the significant others group.
Discussion
The aim of this paper was to answer the question: What dimensions in a HRQOL questionnaire predict the global rating of overall QOL in lung cancer patients? As shown in the result, emotional functioning and fatigue were the dimensions that predicted the assessments of the patients' overall QOL in both the patients' and the significant others' assessments. In addition, in the significant others' assessments, physical functioning was also found to be a predictor. According to Cooley's [9] proposition that HRQOL is antecedent to overall QOL, this could enrich the body of knowledge of QOL in patients with lung cancer. The result that emotional functioning predicts overall QOL is in line with accessible knowledge concerning emotional reactions. Emotions are a fundamental aspect of the human psyche; it is also known that emotional reactions to stressful life events may lead to anxiety, tension, and depression [15] . A WHO study [17] showed that mental ill health, particularly depression that was the most prevalent, led to more functional impairment than physical ill health. A depressed mood is dominated by depressed thoughts directed towards a gloomy view of one's personal history and one's personal state at present as well as in the future [11] . Therefore, the current state of emotional functioning may become a major reference point for overall assessment of QOL. Our results on emotional functioning are supported by other studies; a study on cancer patients with advanced disease revealed anxiety and depression as the predictors of QOL [18] , and a study on a representative sample of Finns [14] strongly indicated that emotional status was the greatest determinant of overall QOL.
Fatigue was the symptom that significantly predicted overall QOL, which is in concordance with what is known about cancer-related fatigue. Fatigue has long been known to have a disruptive effect on patients' lives [28] and has been shown to interfere with patients' QOL. Fatigue is also associated with a range of negative effects, such as physical, emotional, psychological, and social consequences, affecting virtually every aspect of daily life. Patients report that they cannot take part in activities as they used to and, therefore, lose control over part of their lives [13] .
It has previously been suggested that symptom status has no direct effect on overall QOL but is an important determinant for functioning [27] . When only emotional functioning and fatigue were entered in the multiple regression model, this presumption was not supported, as both fatigue and emotional functioning were found to independently predict overall QOL. However, fatigue lost its predictive power when physical functioning was included in the model together with emotional functioning and fatigue. This could be explained by the fact that most items in the physical functioning scale were related to physical activity and that fatigue, therefore, affects overall QOL through physical functioning. In the regression model where all symptoms were entered equally, the overall proportion of variance explained was 22% in both the significant other and the patient groups. This was the lowest level of variance explained of all models. These results may support the presumption that symptom variables affect overall QOL through functioning.
In all other regression models, the overall proportion of variance explained was greater in the significant other group, ranging between 42 and 47%, and lower in the patients group, ranging between 27 and 28%. This indicates that the significant others put more significance in healthrelated aspects in their assessments of the patients overall QOL. Patients, on the other hand, seem to consider other aspect as important for their overall QOL. This could be due to patients adapting to their new health conditions [2] . In the zero-order correlations, several variables correlated significantly with overall QOL, and the pattern was fairly similar between the patients' and the significant others' assessments, with the exception of physical functioning, which did not correlate in the patient assessments. In a study by Arnold et al. [3] on patients with chronic lung disorders (cancer excluded), it was shown that physical functioning correlated with overall QOL and also contributed to the explanation of overall QOL. However, in this group of lung cancer patients, it is possible that emotional concerns are of greater importance in relation to the potentially life-threatening condition of a lung cancer diagnosis. For the significant others' assessments, there was a correlation between physical functioning and overall QOL. In the literature on proxy ratings, when significant others are rating patients' functioning and symptoms [22] , physical functioning is described as concrete, observable, and easy to interpret. This might be why significant others consider that problems in physical functioning affect overall QOL to a greater extent than the patients do themselves. Despite the results on physical functioning, the results of this study suggest that significant others can agree with patients regarding which HRQOL dimensions affect patients' overall QOL on a group level, which may be useful when the patients can no longer speak for themselves. This result is concordant with other studies on using proxies for terminally ill patients [22] .
A wide range of QOL instruments have been developed covering different areas, varying from a global single item for measuring overall QOL to several items for measuring many dimensions of QOL [12] . These various methods have their own strengths and weaknesses [6, 20] . A single global question allows the respondents to consider all aspects of the phenomenon in a personally meaningful way and provides a measure that can be sensitive to individual diversities [12] but may not capture the richness of a multiitem measures [20] . In this study, a single global question of overall QOL was used as the outcome variable. Regarding the use of single-item or multiple-item scores, there is no definitive answer for all situations, but both approaches may have their advantages. If the research question requires a global impression of QOL, as for the outcome variables in this study, a single item may be sufficient [20] . It has also been suggested that, when used as an outcome variable, a concept such as QOL is more appropriately measured with a global single item [6] .
As shown, several correlations between HRQOL dimensions with global ratings of overall QOL were found, but both in patients' and significant others' assessments, emotional functioning and fatigue were the dimensions that predicted the patients' overall QOL. This is important knowledge for understanding the relation between HRQOL and overall QOL in lung cancer patients. Even if emotional impairment is a common reaction and fatigue is a common symptom for cancer patients, the impact of the two on QOL is still under-recognized. The results in this study emphasize that both emotional functioning and fatigue are important as predictors of overall QOL. It is, however, important to have in mind that results on a group level cannot be directly translated into an individual patient level. In this group of severely ill patients with high symptomatology and short life expectancy, these predictors may add relevant knowledge for clinical practice to increase the understanding of important areas for overall QOL.
